MPM BioImpact Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
31
- Investments
-
403
- Portfolio
-
38
- Exits
-
232
MPM BioImpact General Information
Company Description
Founded in 1997, MPM Capital is a venture capital investment firm based in Boston, Massachusetts. The firm prefers to invest in the biotechnology, healthcare, and life sciences sectors in the United States. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.mpmbioimpact.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 399 Boylston Street
- Suite 1100
- Boston, MA 02116
- United States
MPM BioImpact Investments & Acquisitions (403)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Antiva Biosciences | 11-Oct-2024 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Umoja Biopharma | 03-Oct-2024 | Biotechnology | Pre-Clinical Trials | |||
| Aktis Oncology | 20-Sep-2024 | Drug Discovery | Pre-Clinical Trials | |||
| Crane Biotherapeutics | 03-Jun-2024 | Other Commercial Products | Stealth | |||
| Reunion Neuroscience | 02-May-2024 | Media and Information Services (B2B) | Clinical Trials - Phase 2 | |||
| AshiBio | 15-Apr-2024 | Therapeutic Devices | Generating Revenue | |||
| Frontier Medicines | 26-Feb-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| FireFly Bio | 15-Feb-2024 | Drug Discovery | Generating Revenue | |||
| NextPoint | 14-Feb-2024 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| AstronauTx | 02-Oct-2023 | Early Stage VC | Biotechnology | Startup |
MPM BioImpact Exits (232)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| ReNAgade Therapeutics | 22-May-2024 | Merger/Acquisition | |
| Dyne Therapeutics | 05-Jan-2024 | ||
| Oncorus | 01-Jun-2023 | ||
| SiO2 Materials Science | 29-Mar-2023 | ||
| Triplet Therapeutics | 12-Oct-2022 | ||
| Iconic Therapeutics | 01-Jun-2022 | ||
| Entrada Therapeutics | 02-Nov-2021 | ||
| Maverick Therapeutics | 01-Oct-2021 | ||
| Arriva Pharmaceuticals | 30-Apr-2021 | Out of Business | |
| Werewolf Therapeutics | 30-Apr-2021 | IPO |
MPM BioImpact Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
MPM BioImpact Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
MPM BioImpact Co-Investors (153)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 5 |
|
|
||
| Johnson & Johnson Innovation - JJDC |
|
|
|||
| Eli Lilly and Company |
|
|
|||
| Lumira Ventures |
|
|
|||
| Merck & Co. |
|
|
MPM BioImpact Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| BioImpact Capital | Boston, MA | 2015 |
MPM BioImpact FAQs
-
What is MPM BioImpact?
Founded in 1997, MPM Capital is a venture capital investment firm based in Boston, Massachusetts.
-
When was MPM BioImpact founded?
MPM BioImpact was founded in 1997.
-
Where is MPM BioImpact headquartered?
MPM BioImpact is headquartered in Boston, MA.
-
What is MPM BioImpact's total asset value?
MPM BioImpact has around in total assets under management.
-
How many investments has MPM BioImpact made?
MPM BioImpact has made 403 investments.
-
What has MPM BioImpact invested in?
MPM BioImpact has made numerous investments in companies like Antiva Biosciences, Umoja Biopharma, and Aktis Oncology within the Drug Discovery and Biotechnology industries.
-
What has MPM BioImpact invested in recently?
MPM BioImpact's latest investment was on 11-Oct-2024 in Antiva Biosciences, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
